UBS Group »

Fs Global Cr Opportunitie Fda shares owned by UBS Group

Quarter-by-quarter ownership of Fs Global Cr Opportunitie Fda (FSCO) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Fs Global Cr Opportunitie Fda

Tip: Access up to 7 years of quarterly data

All positions including Fs Global Cr Opportunitie Fda held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fs Global Cr Opportunitie Fda by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $211k 37k 5.67
2023-09-30 $183k 34k 5.42
2023-06-30 $256k 54k 4.75
2023-03-31 $97k 22k 4.44
2022-12-31 $1.2M 255k 4.71

More positions owned by UBS Group

Microsoft Corporation (MSFT)
Apple Call Option (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
Amazon Call Option (AMZN)
NVIDIA Corporation (NVDA)
Ubs Group SHS (UBS)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Union Pacific Corporation (UNP)
Alphabet Cap Stk Cl C Put Option (GOOG)
Meta Platforms Cl A (META)

View all positions for UBS Group

Top funds holding Fs Global Cr Opportunitie Fda

Commonwealth Equity Services
Nomura Holdings
Cambridge Investment Research Advisors
Thomas J. Herzfeld Advisors
Saba Capital Management
Wagner Wealth Management
Penserra Capital Management
Advisor Group Holdings
H D Vest Advisory Services
Rockefeller Capital Management
Royal Bank of Canada
Kestra Advisory Services
Ellis Investment Partners
Prime Capital Investment Advisors
Feltz Wealth PLAN

View all funds holding Fs Global Cr Opportunitie Fda